Thorsten Stiewe

56PUBLICATIONS
170CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Genome structure and regulationEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Apr 28, 2026
DARPins as pan-reactivators of temperature-sensitive p53 cancer mutants.

|Feb 26, 2026
Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapopt.

Danai Mavridi, Julianne S Funk, Dimitrios-Ilias Balourdas

|Feb 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer.

Luise von Wichert, Alina Stroh, Marie Witt

|Feb 03, 2026
Secreted luciferases as a minimally invasive 3R-compliant tool for accurate monitoring of tumor burden.

Nastasja Merle, Imke Bullwinkel, Oleg Timofeev

|Jan 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

Andreas Burchert, Franck E Nicolini, Philipp le Coutre

|Jun 23, 2025
Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes.

Jan Dreute, Julia Stengel, Jonas Becher

Pageof 10

Frequent Collaborators

6 joint publications

Rajkumar Savai

6 joint publications

Andreas C Joerger

5 joint publications

Julianne S Funk

5 joint publications

Robert Liefke